Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13
- DOI
- 10.1586/17474124.2015.1091304
- Published
- 2015-09-22
- Container
- Expert Review of Gastroenterology & Hepatology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1586/17474124.2015.1091304,
title = {Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13},
author = {Stefan Schreiber and Julian Panés and ByoungOh Kwon and SeungSuh Hong and Laurent Peyrin-Biroulet},
year = {2015},
journal = {Expert Review of Gastroenterology \& Hepatology},
doi = {10.1586/17474124.2015.1091304},
url = {https://doi.org/10.1586/17474124.2015.1091304}
}RIS
TY - JOUR TI - Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13 AU - Stefan Schreiber AU - Julian Panés AU - ByoungOh Kwon AU - SeungSuh Hong AU - Laurent Peyrin-Biroulet PY - 2015 JO - Expert Review of Gastroenterology & Hepatology DO - 10.1586/17474124.2015.1091304 UR - https://doi.org/10.1586/17474124.2015.1091304 ER -
APA
Schreiber, S., Panés, J., Kwon, B., Hong, S., & Peyrin-Biroulet, L. (2015). Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13. Expert Review of Gastroenterology & Hepatology. https://doi.org/10.1586/17474124.2015.1091304
Source records
- crossref · retrieved 2026-09-26T22:38:16.764Z